The Improving Home Dialysis Act of 2026 (H.R. 8875) aims to enhance Medicare coverage for individuals undergoing dialysis at home. Starting January 1, 2028, the bill proposes to include two new services: (1) Staff-Assisted Home Dialysis Respite Care, providing temporary professional assistance during the initial 30 days of home dialysis or when patients face physical limitations, limited to 20 sessions per year; and (2) Renal Mental Health Services, offering up to four mental health sessions within the first 60 days of starting home dialysis. These additions are designed to support patients transitioning to home-based dialysis and address challenges they may encounter.
The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) have expressed strong support for H.R. 8875. The NKF highlighted the bill as a significant step toward making home dialysis more accessible, emphasizing its potential to help patients remain at home and reduce care disruptions. Similarly, ASN President Dr. Samir M. Parikh praised the legislation for expanding options for Americans with kidney failure and commended Representative Carol Miller's commitment to innovative kidney care solutions.
As of now, there is limited media coverage presenting negative reactions to H.R. 8875. Potential concerns that may arise include the financial implications of expanding Medicare coverage without specified funding, which could impact the program's budget. Additionally, the effectiveness of the proposed services in improving patient outcomes and the readiness of healthcare providers to implement these changes might be questioned. However, such critiques have not been prominently featured in current media reports.
The analysis of H.R. 8875, the Improving Home Dialysis Act of 2026, reveals no direct industry overlaps between the subject matter of the bill and the sponsor, Carol Miller's, top donor industries. This lack of overlap suggests that there are minimal immediate financial conflicts of interest that could influence the legislative process. The absence of significant contributions from industries related to home dialysis or healthcare indicates that the bill is unlikely to be swayed by donor interests. Voters should note that while campaign finance can often lead to perceived conflicts, in this case, the data supports a low risk of undue influence based on the current donor landscape.
Top industries funding Carol Miller, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
